Home > News > BioForce Announces New Sale to Harvard Medical School
November 9th, 2006
BioForce Announces New Sale to Harvard Medical School
Abstract:
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
(OTC Bulletin Board: BFNH.OB), announced today the completion of a NanoeNabler(TM) system sale to the Technology & Engineering Center at Harvard Medical School.
Source:
PR Newswire
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Homeland Security
The picture of health: Virginia Tech researchers enhance bioimaging and sensing with quantum photonics June 30th, 2023
Sensors developed at URI can identify threats at the molecular level: More sensitive than a dog's nose and the sensors don't get tired May 21st, 2021
Highly sensitive dopamine detector uses 2D materials August 7th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||